Castle Biosciences CSTL
NASDAQ CSTL
$34.74 -0.25 (-0.70%)
As of: Sep 22, 2026 · 10:48 AM EDT

Castle Biosciences (CSTL) Capital Expenditures Growth (5y) (2023 - 2026)

Analysis

Castle Biosciences (CSTL) Capital Expenditures Growth (5y) (2023 - 2026) Analysis & Trends

Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr)
1 Natera 53.05 Bn 51.95 Bn 486.15 Mn
2 Quest Diagnostics 27.19 Bn 26.87 Bn 1.03 Bn
3 Labcorp Holdings 25.93 Bn 25.81 Bn 1.11 Bn
4 Guardant Health 23.97 Bn 22.91 Bn 219.03 Mn
5 Tempus AI 13.64 Bn 12.82 Bn 274.25 Mn
6 Caris Life Sciences 8.47 Bn 7.68 Bn 182.38 Mn
7 Sotera Health 5.35 Bn 4.99 Bn 177.96 Mn
8 BillionToOne 4.96 Bn 4.41 Bn 77.11 Mn
9 Adaptive Biotechnologies 4.55 Bn 4.21 Bn 51.39 Mn
10 Castle Biosciences 1.08 Bn 811.36 Mn 79.85 Mn
Historic Data

Historic Data

Download Data
DateValue
Jun 30, 2026 -23.23%
Mar 31, 2026 75.41%
Dec 31, 2025 64.91%
Sep 30, 2025 50.74%
Jun 30, 2025 39.46%
Mar 31, 2025 56.81%
Dec 31, 2024 85.23%
Sep 30, 2024 107.45%
Jun 30, 2024 96.17%
Mar 31, 2024 106.45%
Dec 31, 2023 271.23%
Sep 30, 2023 95.03%
API Access

Castle Biosciences Capital Expenditures Growth (5y) API

Pull this series into your own models, spreadsheets and apps with the Business Quant Historical Metrics API. The request below matches the chart above — change the frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.

https://data.businessquant.com/historic?slug=capital-expenditures-growth-5y&ticker=CSTL&period=max&api_key=YOUR_API_KEY